Table 2.

Incidence of high-risk human papillomavirus types in HIV-positive and HIV-negative participants (N=264)

	HIV-Positive (n=163)					HIV-Negative (n=101)
HPV Type	Baseline n(%)	Incidence (number)	Person-Months	Incidence/1000 Person-Months (95% CI)	12-Month Incidence(%) (95% CI)	Baseline n(%)	Incidence (number)	Person-Months	Incidence/1000 Person-Months (95% CI)	12-Month Incidence(%) (95% CI)	IRR (95% CI)	p-value
HPV16	40(18.9)	10	1460.6	6.8(3.7-12.7)	8.2(4.4-15.2)	18(13.6)	3	1074.0	2.8(0.9-8.7)	3.3(1.1-10.4)	2.5(0.6-13.9)	0.17
HPV18	28(13.2)	7	1600.8	4.4(2.1-9.2)	5.2(2.5-11)	13(9.9)	2	1130.7	1.8(0.4-7.1)	2.1(0.5-8.5)	2.5(0.5-24.4)	0.27
HPV31	10(4.7)	1	1796.7	0.6(0.1-4)	0.7(0.1-4.7)	2(1.5)	1	1241.3	0.8(0.1-5.7)	1(0.1-6.8)	0.7(0-54.2)	0.82
HPV33	13(6.1)	2	1732.3	1.2(0.3-4.6)	1.4(0.3-5.5)	0(0)	0	0.0	0(0-0)	0(0-0)
HPV35	9(4.3)	1	1775.1	0.6(0.1-4)	0.7(0.1-4.8)	1(0.8)	0	0.0	0(0-0)	0(0-0)
HPV39	17(8)	4	1675.6	2.4(0.9-6.4)	2.9(1.1-7.6)	8(6.1)	0	0.0	0(0-0)	0(0-0)
HPV45	15(7.1)	1	1742.5	0.6(0.1-4.1)	0.7(0.1-4.9)	7(5.3)	0	0.0	0(0-0)	0(0-0)
HPV51	30(14.2)	5	1582.8	3.2(1.3-7.6)	3.8(1.6-9.1)	15(11.4)	2	1113.2	1.8(0.4-7.2)	2.2(0.5-8.6)	1.8(0.3-18.5)	0.53
HPV52	16(7.6)	7	1683.2	4.2(2-8.7)	5(2.4-10.4)	17(12.9)	0	0.0	0(0-0)	0(0-0)
HPV56	9(4.3)	3	1784.6	1.7(0.5-5.2)	2(0.6-6.2)	2(1.5)	0	0.0	0(0-0)	0(0-0)
HPV58	25(11.8)	5	1607.4	3.1(1.3-7.5)	3.7(1.6-8.9)	9(6.8)	0	-	-	0(0-0)
HPV59	29(13.7)	10	1579.0	6.3(3.4-11.8)	7.6(4.1-14.1)	11(8.3)	0	-	-	0(0-0)
HPV68	21(9.9)	2	1656.4	1.2(0.3-4.8)	1.4(0.4-5.8)	10(7.6)	3	1161.0	2.6(0.8-8)	3.1(1-9.6)	0.5(0-4.1)	0.44
Any high-risk HPV	141(66.5)	13	457.7	28.4(16.5-48.9)	34(19.8-58.6)	67(50.8)	8	576.5	13.9(6.9-27.7)	16.6(8.3-33.2)	2(0.8-5.7)	0.056

HPV, human papillomavirus; CI, confidence interval; IRR, incidence rate ratio.